Yuyu Pharma Expands Solar Power at Manufacturing Facility, Bringing On-Site Capacity to 1 MW

PR NewswireSep 14, 2026 1:00 PM

View all comments（0）



New solar installation expected to supply more than 30% of the factory's electricity needs and pay for itself in approximately three years

SEOUL, South Korea, Sept. 14, 2026 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) has completed a major expansion of solar power at its manufacturing facility in Korea, bringing the site's total on-site solar capacity to approximately 1 megawatt (MW). The new 869-kilowatt (kW) solar system builds on earlier installations of 30 kW in 2020 and 96.6 kW in 2021. Together, the solar systems are expected to provide more than 30% of the electricity used at the manufacturing facility.

The newest installation is expected to generate at least 1.2 million kilowatt-hours (kWh) of electricity annually. Over 25 years, Yuyu Pharma estimates that it could generate approximately 30.96 million kWh of electricity.

The project is designed to deliver both environmental and economic benefits. By generating more electricity on-site, Yuyu Pharma expects to reduce its dependence on purchased electricity and lower long-term operating costs. Based on the company's current projections, the investment is expected to pay for itself in approximately three years.

"Solar power makes environmental and economic sense for Yuyu. We can generate more of our own electricity, reduce long-term operating costs, and make our factory more resilient," said Robert Wonsang Yu, CEO of Yuyu Pharma. "For an 85-year-old company, staying competitive means continuing to invest in how the next generation of Yuyu will operate."

The solar expansion is part of Yuyu Pharma's broader effort to modernize its operations while improving efficiency and sustainability. Founded in 1941, Yuyu Pharma has continued to evolve alongside Korea's healthcare industry. The company views investments in areas such as renewable energy and smarter manufacturing as part of preparing its operations for the decades ahead.

About Yuyu Pharma

Founded in 1941, Yuyu Pharma (KRX: 000220) is a Korea-based healthcare company focused on pharmaceuticals, medical devices, and health supplements that improve quality of life. As part of its global growth strategy, the company invests in early-stage and high-growth innovators across biotechnology, sustainability, and animal health through Yuyu Venture Studio.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?

TradingKey - At the Connect 2026 conference held from September 23 to 24, Meta (META) unveiled the Ray-Ban Meta Audio, third-generation Ray-Ban Meta, and Meta VR Glasses, while upgrading the Meta Ray-Ban Display. The company also announced the integration of its personal AI agent, Muse, into its AI glasses, expanding its product scope from mobile phones and social apps to wearable devices.

Today’s Market Recap: 10-Year Treasury Yield Hits Highest Level Since 2007, Major U.S. Indexes Fall, SpaceX Drops Over 4%

TradingKey — Rising Treasury yields and oil prices weighed on U.S. equities, sending all three major indexes lower. On September 23, the 10-year Treasury yield climbed to its highest level since July 2007, while rebounding crude prices intensified concerns over inflation and interest rates. Technolo

Japan Stocks Open Higher After Three-Day Holiday, SoftBank Rises Over 6%, Kioxia Up Nearly 4%; South Korean Markets Closed

TradingKey - On September 24, Japanese stock markets resumed trading after a three-day holiday, with the Nikkei 225 Index (JPN225) opening 0.6% higher and later extending gains to 1.25% to reach 65,828.43 points. Meanwhile, South Korean stock markets were closed for a holiday.

【US Pre-Market】Nasdaq Leads Losses in Three Major Stock Index Futures, IONQ Surges Over 11%, RGTI Rises Over 5% as Market Focuses on US-China Summit

TradingKey - On Wednesday (September 23) Eastern Time, futures tied to the three major U.S. stock indexes edged up in pre-market trading. Diplomatic mediation in the Middle East and the restoration of a key Saudi oil pipeline kept international oil prices below $100 per barrel, temporarily easing energy inflation concerns. Meanwhile, investors are awaiting the summit between Chinese and U.S. leaders and the preliminary U.S. September PMI data, while a strengthening U.S. dollar and the risk of further Federal Reserve rate hikes continue to cap market gains.

The Week Ahead: US-China Summit in Washington, Costco Earnings and Fed Rate Path in Focus

TradingKey - During the week of September 21 to 25, Eastern Time, the US stock market will focus on the meeting between Chinese and US leaders, the Federal Reserve's policy outlook, and economic data such as US new home sales and durable goods orders.

Featured Tools